Fig 4. p53 protein expression by TGRL lipolysis products was suppressed by TGF-β receptor inhibitor, ALK.

Western Blot (a) and densitometry quantification (b) for p53. p53 expression is significantly increased after 1.5 h of treatment with lipolysis products (TL1.5) compared to control cells (M). Treatment with TGRL (T) or LpL (L) does not alter p53 protein content. N = 3/treatment group, * = P≤0.05. Expression declines after 3 h of treatment with lipolysis products (TL3) P≤0.1.